Lodenafil
Like udenafil and avanafil it belongs to a new generation of PDE5 inhibitors.This formulation has higher oral bioavailability than the parent drug.[1] It is manufactured by Cristália Produtos Químicos e Farmacêuticos in Brazil and sold there under the brand-name Helleva.[2] It has undergone Phase III clinical trials,[3][4] but is not yet approved for use in the United States by the U.S. Food and Drug Administration.This drug article relating to the genito-urinary system is a stub.
PregnancycategoryRoutes ofadministrationBy mouthLegal statusIUPAC nameCAS NumberChemSpiderCompTox DashboardFormulaMolar massSMILESPDE5 inhibitorsildenafiltadalafilvardenafiludenafilavanafilprodrugcarbonate esterbioavailabilityBrazilUnited StatesU.S. Food and Drug AdministrationHomosildenafilWayback MachineSexual dysfunctionpharmacotherapiesDopamine agonistsApomorphineCabergolineLisuridePergolidePiribedilPramipexoleQuinagolideRopiniroleRotigotineTergurideMelanocortin agonistsBremelanotideMelanotan IIPL-6983PDE5 inhibitorsAcetildenafilAildenafilIcariinMirodenafilNitrosoprodenafilSulfoaildenafilSex steroidsAndrogenstestosteronemethyltestosteroneanabolic steroidsEstrogensestradiolethinylestradiolconjugated equine estrogensPremarinProgestogensprogesteroneprogestinstiboloneacecarbromalquebrachovitamin EAlkyl nitritesAlprostadilAmantadineBupropionBuspironeCyproheptadineDapoxetineFlibanserinMirtazapineMoxisylyteOxytocinPapaverinePhentolaminePsychostimulantsamphetaminescocainemethylphenidateRauwolscineRauvolfiaTrazodoneYohimbineYohimbePhosphodiesterase inhibitorsSCH-51866VinpocetineBAY 60-7550OxindoleAdibendanAmrinone (inamrinone)AnagrelideBucladesineCilostamideCilostazolEnoximoneEnsifentrineKMUP-1MilrinoneOlprinonePimobendanQuazinoneRPL-554SiguazodanTrequinsinVesnarinoneZardaverineApremilastArofyllineAtizoramCC-1088CilomilastCrisaboroleDrotaverineEtazolateFilaminastGlaucineHT-0712ICI-63197IrsogladineLuteolinMesembrenone